Clinical Trial Update: Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports safety outcomes and priming immune responses for an HIV vaccine regimen in healthy, HIV-uninfected adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: HIV Vaccine Trials Network | Conditions: HIV Infections | Phase 1 | Status: COMPLETED